Sachdev Amit's Form 4 filing
Vertex Pharmaceuticals IncVRTX · filed Feb 23, 2026
- Accession no.
- 0000875320-26-000102
- Filed
- Feb 23, 2026
- Trade date
- Feb 19, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $27.5M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sachdev AmitCIK 0001406338 | Officer (EVP Chief Patient & Ext Af Off) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +23,479 | $155.57 | +$3,652,628.03 | 92,521 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +25,026 | $187.53 | +$4,693,125.78 | 117,547 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −920 | $463.91F2,F3 | −$426,797.2 | 116,627 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −2,730 | $465.05F3,F4 | −$1,269,586.5 | 113,897 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −1,848 | $465.80F3,F5 | −$860,798.4 | 112,049 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −10,263 | $467.75F3,F6 | −$4,800,518.25 | 101,786 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −19,662 | $468.57F3,F7 | −$9,213,023.34 | 82,124 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −7,241 | $469.61F3,F8 | −$3,400,446.01 | 74,883 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −11,712 | $470.54F3,F9 | −$5,510,964.48 | 63,171 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −4,237 | $471.43F3,F10 | −$1,997,448.91 | 58,934 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −23,479 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −25,026 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Open market sales reported on this line occurred at a weighted average price of $463.91 (range $463.44 to $464.28).
Referenced by the price of 1 transaction in Table I.
- F3
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 8 transactions in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $465.05 (range $464.48 to $465.46).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $465.80 (range $465.54 to $466.49).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $467.75 (range $467.09 to $468.05).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $468.57 (range $468.10 to $469.09).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $469.61 (range $469.10 to $470.05).
Referenced by the price of 1 transaction in Table I.
- F9
Open market sales reported on this line occurred at a weighted average price of $470.54 (range $470.10 to $471.08).
Referenced by the price of 1 transaction in Table I.
- F10
Open market sales reported on this line occurred at a weighted average price of $471.43 (range $471.10 to $472.03).
Referenced by the price of 1 transaction in Table I.